Abstract
MUC7 16-mer (residues 36-51 of human salivary mucin, MUC7) and histatin 5 possess potent in vitro antifungal activity. In the present study, we have evaluated the efficacy of these peptides in vivo using the experimental model of murine vulvo-vaginal candidiasis. The treatment groups included MUC7 16-mer, histatin 5, clotrimazole (all in pluronic F127 gel), and placebo (gel alone). Mice were treated intravaginally for 7 consecutive days. At the end of the treatment, anticandidal activities were assessed by colony counts and by histological examination. All groups except clotrimazole presented positive cultures; no statistically significant differences were found in fungal burden amongst placebo and any treatment group except clotrimazole. Histopathological findings confirmed the microbiological results; all groups with the exception of clotrimazole showed variable signs of infection.
| Original language | English |
|---|---|
| Pages (from-to) | 594-600 |
| Number of pages | 7 |
| Journal | International Journal of Antimicrobial Agents |
| Volume | 22 |
| Issue number | 6 |
| DOIs | |
| State | Published - Dec 2003 |
Keywords
- Anticandidal agents
- Candida albicans
- Clotrimazole
- In vivo
- Pluronic F127
Fingerprint
Dive into the research topics of 'Efficacy of human salivary mucin MUC7-derived peptide and histatin 5 in a murine model of candidiasis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver